P

Usamos cookies essenciais, analíticas e publicidade para melhorar a experiência, medir a utilização e otimizar campanhas.

Essenciais

Necessárias para o funcionamento do site e não podem ser desativadas.

Analíticas

Ajudam-nos a compreender o uso para melhorar o serviço.

Permitem medir campanhas e otimizar publicidade relacionada com os nossos serviços.

Saiba mais em Política de Privacidade · Termos de Serviço · Política de Cookies

Guardar

Pending

HORIZON-MISS-2027-02-CANCER-02International

Pending

Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancers

Horizon Europe

Description

Europe

Health & Life Sciences•100% • 20M€

Pending

Dates & Deadlines

Publication Date

Not defined

Opening Date

February 10, 2027

Application Phases

Fase única

September 16, 2027 at 05:00 PM

Financial Details

Non-Refundable

Maximum Funding Rate

100%

Budget

20M€

Eligible Project Value

7M€ - 10M€

Criteria & Documents

Eligible Expenses

●Personnel Costs
●Travel costs
●Equipment costs
●Other goods, works and services costs
●Subcontracting
●Indirect Costs

Access Conditions

●Legal entities from EU Member States and Associated Countries
●Consortium must include partners from at least three different EU Member States or Associated Countries
●Compliance with general and specific admissibility and eligibility criteria

Selection Criteria

●Excellence (scientific and technical merit)
●Impact (contribution to policy and partnership KPIs)
●Quality and efficiency of implementation

Mandatory Information

●Application form (Part A and Part B)
●Budget
●Clinical study annex (submission system template)

Result Indicators

●Number of-pilot clinical research programmes implemented
●Countries covered (especially those with less developed infrastructures)
●Degree of data sharing and metadata completeness
●Stakeholder engagement level
●Implementation of innovative diagnostic/treatment protocols

EU Programme Details

Call ID: HORIZON-MISS-2027-02-CANCER-02
Cluster: Mission
Destination: Cancer
Submission Mode: Single-stage
EU Contribution: Around €7,000,000.00 to €10,000,000.00 per project
Expected Projects: 3 projects
Funding Rate Rule: Up to 70% for Innovation Actions (up to 100% for non-profit entities only)

Guardar

Pending

HORIZON-MISS-2027-02-CANCER-02International

Pending

Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancers

Horizon Europe

Description

Europe

Health & Life Sciences•100% • 20M€

Pending

Dates & Deadlines

Publication Date

Not defined

Opening Date

February 10, 2027

Application Phases

Fase única

September 16, 2027 at 05:00 PM

Financial Details

Non-Refundable

Maximum Funding Rate

100%

Budget

20M€

Eligible Project Value

7M€ - 10M€

Criteria & Documents

Eligible Expenses

●Personnel Costs
●Travel costs
●Equipment costs
●Other goods, works and services costs
●Subcontracting
●Indirect Costs

Access Conditions

●Legal entities from EU Member States and Associated Countries
●Consortium must include partners from at least three different EU Member States or Associated Countries
●Compliance with general and specific admissibility and eligibility criteria

Selection Criteria

●Excellence (scientific and technical merit)
●Impact (contribution to policy and partnership KPIs)
●Quality and efficiency of implementation

Mandatory Information

●Application form (Part A and Part B)
●Budget
●Clinical study annex (submission system template)

Result Indicators

●Number of-pilot clinical research programmes implemented
●Countries covered (especially those with less developed infrastructures)
●Degree of data sharing and metadata completeness
●Stakeholder engagement level
●Implementation of innovative diagnostic/treatment protocols

EU Programme Details

Call ID: HORIZON-MISS-2027-02-CANCER-02
Cluster: Mission
Destination: Cancer
Submission Mode: Single-stage
EU Contribution: Around €7,000,000.00 to €10,000,000.00 per project
Expected Projects: 3 projects
Funding Rate Rule: Up to 70% for Innovation Actions (up to 100% for non-profit entities only)